Javascript must be enabled to continue!
Early risk predictors of acute kidney injury and short-term survival during Impella support in cardiogenic shock
View through CrossRef
AbstractAcute kidney injury (AKI) is one of the most frequent and prognostic-relevant complications of cardiogenic shock (CS) complicating myocardial infarction (MI). Mechanical circulatory assist devices (MCS) like left ventricular Impella microaxial pump have increasingly been used in the last decade for stabilization of hemodynamics in those patients. Moreover, a protective effect of Impella on renal organ perfusion could recently be demonstrated. However, data identifying early risk predictors for developing AKI during Impella support in CS are rare. Data of hemodynamics and renal function from 50 Impella patients (January 2020 and February 2022) with MI-related CS (SCAI stage C), were retrospectively analyzed using e.g. multivariate logistic regression analysis as well as Kaplan–Meier curves and Cox regression analysis. 30 patients (60%) developed AKI. Central venous pressure as an indicator for venous congestion (OR 1.216, p = 0.02), GFR at admission indicating existing renal damage (OR 0.928, p = 0.002), and reduced central venous oxygen saturation (SvO2) as a marker for decreased tissue perfusion (OR 0.930, p = 0.029) were independently associated with developing an AKI. The 30-day mortality rate was significantly higher in patients with AKI stage 3 (Stage 1: 0%, Stage 2: 0%, Stage 3; 41.6%, p = 0.014) while AKI stage 3 (HR 0.095, p = 0.026) and norepinephrine dosage (HR 1.027, p = 0.008) were independent predictors for 30-day mortality. AKI as a complication of MI-related CS occurs frequently with a major impact on prognosis. Venous congestion, reduced tissue perfusion, and an already impaired renal function are independent predictors of AKI. Thus, timely diagnostics and a focused treatment of the identified factors could improve prognosis and outcome.
Springer Science and Business Media LLC
Title: Early risk predictors of acute kidney injury and short-term survival during Impella support in cardiogenic shock
Description:
AbstractAcute kidney injury (AKI) is one of the most frequent and prognostic-relevant complications of cardiogenic shock (CS) complicating myocardial infarction (MI).
Mechanical circulatory assist devices (MCS) like left ventricular Impella microaxial pump have increasingly been used in the last decade for stabilization of hemodynamics in those patients.
Moreover, a protective effect of Impella on renal organ perfusion could recently be demonstrated.
However, data identifying early risk predictors for developing AKI during Impella support in CS are rare.
Data of hemodynamics and renal function from 50 Impella patients (January 2020 and February 2022) with MI-related CS (SCAI stage C), were retrospectively analyzed using e.
g.
multivariate logistic regression analysis as well as Kaplan–Meier curves and Cox regression analysis.
30 patients (60%) developed AKI.
Central venous pressure as an indicator for venous congestion (OR 1.
216, p = 0.
02), GFR at admission indicating existing renal damage (OR 0.
928, p = 0.
002), and reduced central venous oxygen saturation (SvO2) as a marker for decreased tissue perfusion (OR 0.
930, p = 0.
029) were independently associated with developing an AKI.
The 30-day mortality rate was significantly higher in patients with AKI stage 3 (Stage 1: 0%, Stage 2: 0%, Stage 3; 41.
6%, p = 0.
014) while AKI stage 3 (HR 0.
095, p = 0.
026) and norepinephrine dosage (HR 1.
027, p = 0.
008) were independent predictors for 30-day mortality.
AKI as a complication of MI-related CS occurs frequently with a major impact on prognosis.
Venous congestion, reduced tissue perfusion, and an already impaired renal function are independent predictors of AKI.
Thus, timely diagnostics and a focused treatment of the identified factors could improve prognosis and outcome.
Related Results
Renal Protection and Hemodynamic Improvement by Impella® Microaxial Pump in Patients with Cardiogenic Shock
Renal Protection and Hemodynamic Improvement by Impella® Microaxial Pump in Patients with Cardiogenic Shock
Acute kidney injury is one of the most frequent and prognostically relevant complications in cardiogenic shock. The purpose of this study was to evaluate the potential effect of th...
Increasing use of the Impella®-pump in severe cardiogenic shock: a word of caution
Increasing use of the Impella®-pump in severe cardiogenic shock: a word of caution
Abstract
Impella® pumps are increasingly utilized in patients in cardiogenic shock. We report on a case series where Impella support was insufficient, and a switch t...
Pitfalls due to improper positioning of Impella®CP device for left ventricular support: a case series
Pitfalls due to improper positioning of Impella®CP device for left ventricular support: a case series
Background: The Impella® device is a type of antegrade left ventricular assist device that includes a pump catheter designed to reside in the mid-left ventricular cavity. It has re...
IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study
IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study
Cardiogenic shock (CS) is part of a clinical syndrome consisting of acute left ventricular failure causing severe hypotension leading to inadequate organ and tissue perfusion. The ...
IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study
IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study
Cardiogenic shock (CS) is part of a clinical syndrome consisting of acute left ventricular failure causing severe hypotension leading to inadequate organ and tissue perfusion. The ...
Characteristics and outcomes of combination VA-ECMO for cardiogenic shock
Characteristics and outcomes of combination VA-ECMO for cardiogenic shock
Abstract
Background
Use of VA-ECMO for cardiogenic shock is growing exponentially. The impact of VA-ECMO on in-hospital mortalit...
Cardiogenic shock: role of invasive cardiology
Cardiogenic shock: role of invasive cardiology
Purpose of review
Early revascularization significantly improved the outcome of patients with cardiogenic shock following acute myocardial infarction (AMI). Nevertheles...
Prevalence and Clinical Outcomes of Acute Noncardiac Organ Failure among Non-Acute Myocardial Infarction Cardiogenic Shock: A Nationwide Cohort Analysis
Prevalence and Clinical Outcomes of Acute Noncardiac Organ Failure among Non-Acute Myocardial Infarction Cardiogenic Shock: A Nationwide Cohort Analysis
AbstractBackgroundNoncardiac organ failure often complicates cardiogenic shock (CS). The results of cardiogenic shock caused by noncardiac organ failures in patients without acute ...

